GGrantIndex
Sort

38,696 grants matching als

Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis

$805,870
Gary K Owens · University Of Virginia · R01 · FY2023 · HL

Restoration of olfactory neural circuitry following disruption.

$805,860
Leonardo Belluscio · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS

GENETICS OF ADOLESCENT ANTISOCIAL DRUG DEPENDENCE

$805,850
University Of Colorado Denver · R01 · FY2003 · DA

Molecular anatomy of human alveolar development

$805,830
David Warburton · Children'S Hospital Of Los Angeles · U01 · FY2015 · HL

Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024

$805,727
Deborah S. Hasin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2019 · DA

Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs

$805,568
Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2022 · AI

Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD

$805,554
Rita Sattler · St. Joseph'S Hospital And Medical Center · R01 · FY2023 · NS

BRAIN project: OpenNeuroPET: An Archive for PET data

$805,300
Robert Innis · National Institute Of Mental Health · ZIA · FY2023 · MH

Advanced neural decoders for the restoration of communication

$805,287
Jaimie M Henderson · Stanford University · R01 · FY2015 · DC

In vivo studies of neural system in zebrafish

$805,249
Fumihito Ono · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Genetic Epidemiology of Complex Traits

$805,033
Joan E. Bailey-Wilson · Human Genome Research · Z01 · FY2007 · HG

Use of induced pluripotent stem cells to study mechanims of familial and sporadic

$805,000
Thomas P Maniatis · Columbia University Health Sciences · DP1 · FY2010 · OD

Prospective immune profiling using methylation markers and pancreatic cancer risk

$804,995
Dominique S Michaud · Tufts University Boston · R01 · FY2017 · CA

Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS

$804,869
Victor Lobanenkov · Niaid Extramural Activities · Z01 · FY2007 · AI

Kansas Community Cancer Health Disparities Network

$804,752
K Allen Greiner · University Of Kansas Medical Center · U54 · FY2010 · CA

A Randomized Controlled Trial of A Digital, Self-Guided, Avatar Assisted- Cognitive Behavioral Therapy Platform to Treat Addiction: Digital RITch®CBT vs. Standard CBT

$804,694
Caroline J. Easton · Rochester Institute Of Technology · UG3 · FY2022 · DA

Measuring Improvement in the Quality of ED-initiated Treatment for OUD using Observation

$804,473
Ryan P McCormack · New York University School Of Medicine · R33 · FY2022 · DA

Experimental Therapeutics of Pediatric Hematopoietic Malignancies

$804,284
Alan S Wayne · Division Of Clinical Sciences - Nci · ZIC · FY2012 · CA

Dissonance Eating Disorder Prevention: Clinician-Led, Peer-Led, vs Web-Delivered

$804,272
Eric M Stice · Oregon Research Institute · R01 · FY2015 · MH

EFFECTIVENESS OF COMMUNITY SERVICES FOR CONDUCT PROBLEMS

$804,174
University Of Pittsburgh At Pittsburgh · R01 · FY2000 · MH

Section on High Resolution Optical Imaging

$803,745
Hari Shroff · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2010 · EB

Exploitation of multiple heteroresistance for effective antibiotic combination therapy

$803,714
David S Weiss · Emory University · R01 · FY2023 · AI

Exploitation of multiple heteroresistance for effective antibiotic combination therapy

$803,714
David S Weiss · Emory University · R01 · FY2021 · AI

Exploitation of multiple heteroresistance for effective antibiotic combination therapy

$803,714
David S Weiss · Emory University · R01 · FY2022 · AI

Molecular anatomy of human alveolar development

$803,684
David Warburton · Children'S Hospital Of Los Angeles · U01 · FY2017 · HL